Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Others don't budge
A 2025 systematic review by Vasireddi and colleagues in HSS Journal screened 544 published papers and identified 36 meeting inclusion criteria 35 preclinical studies and only one human study: an uncontrolled, unblinded, retrospective case series of 12 patients receiving intra-articular BPC-157 for chronic knee pain, in which 7 of 12 (58%) reported self-described relief lasting more than 6 months, with no dose, effect size, or systematically collected adverse events published
Multiple-Dose Flexibility: Contains benzyl alcohol as a preservative, allowing for repeated withdrawals from the same vial
$399.99 Select this Treatment Oral B12 Troches Program
We believe in support our customers and empowering them to make decisions about their health and wellbeing by providing expert advice and information
Article written by Jordan White Founder of URBAN Medical Content reviewed by Dr
